Cargando…
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care
BACKGROUND: National guidelines and initiatives have promoted the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) for patients with diabetes. The University of Arizona Medication Management Center (UA-MMC) is contracted by Medicare health plans, pharm...
Autores principales: | Hurwitz, Jason T., Grizzle, Amy J., Augustine, Jill, Rehfeld, Rick, Wild, Ann, Abraham, Ivo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398078/ https://www.ncbi.nlm.nih.gov/pubmed/27015050 http://dx.doi.org/10.18553/jmcp.2016.22.1.40 |
Ejemplares similares
-
ACEIs and ARBs and Their Correlation with COVID-19: A Review
por: Yehualashet, Awgichew Shewasinad, et al.
Publicado: (2020) -
The role of ACEIs/ARBs in COVID-19: Friend or foe?
por: Zhou, Zhe, et al.
Publicado: (2020) -
Withdrawal of ACEIs or ARBs in hospitalised patients with COVID-19
Publicado: (2021) -
ACEI inhibitors and ARBs do not increase severity of COVID-19
Publicado: (2020) -
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)